Nils Cordes

17PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapyRehabilitation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 16, 2025
Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.

Bin Lan, Siyuan Zeng, Shuman Zhang

|Apr 15, 2025
A novel role of exostosin glycosyltransferase 2 (EXT2) in glioblastoma cell metabolism, radiosensitivity and ferroptosis.

Rocío Matesanz-Sánchez, Mirko Peitzsch, Inga Lange

|Nov 11, 2022
Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance.

Sandra Classen, Elena Rahlf, Johannes Jungwirth

|Oct 11, 2022
Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma.

Irina Korovina, Anne Vehlow, Achim Temme

|Jul 27, 2022
Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair.

Leon J Blankenstein, Nils Cordes, Leoni A Kunz-Schughart

|Feb 23, 2022
Growth factor receptor and β1 integrin signaling differentially regulate basal clonogenicity and radiation survival of fibroblasts via a modulation of cell cycling.

Anne Vehlow, Nils Cordes

Pageof 3

Frequent Collaborators

4 joint publications

Anne Vehlow

2 joint publications

Erik H J Danen

2 joint publications

Bin Lan

2 joint publications

Yuming Xing